
Surgnova
赛诺微医疗
Surgnova
Biotech/Healthcare
Founded in 2015, SinoMicro (Sainuowei) focuses on minimally invasive surgery and tumor interventional therapy. It has built three platforms—surgical visualization, surgical energy, and tumor ablation—and provides overall minimally invasive surgical treatment solutions worldwide.
Latest round: Series C (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.